Antitubercular activity and pharmacokinetics of rifampicin
Ginzburg, T.S.; Drabkina, R.O.
Antibiotiki 17(7): 607-611
1972
ISSN/ISBN: 0003-5637 PMID: 4655011 Document Number: 46410
Document emailed within 1 workday
Related Documents
Zyczyński, T. 1972: Rifampicin: a new antitubercular agent Wiadomosci Lekarskie 25(3): 251-254Favez, G. 1970: A new antitubercular agent: rifampicin Schweizerische Rundschau für Medizin Praxis 59(8): 296-297
Blanchon, P.; Paillas, J.; Groseille, Y.; Holler, A.; Blanchon, F. 1974: Classification of liver incidents occurring during antitubercular treatments which include rifampicin Annales de Medecine Interne 125(12): 919-922
Almansa de Cara, S. 1972: Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid) Revista Clinica Espanola 125(4): 353-356
Richard, C.; Quevauvilliers, J. 1983: Acute adrenal insufficiency induced by antitubercular treatment in an addisonian woman. Possible role of the rifampicin-isoniazid combination Presse Medicale 12(12): 767-768
Waisser, K.; Celadník, M.; Sova, J.; Palát, K. 1975: Antitubercular agents. XVI. use of HMO computations in the study of structure-activity relationship of antitubercular agents. IIi Ceskoslovenska Farmacie 24(10): 423-426
Acocella, G. 1984: Pharmacokinetics of antitubercular agents in man Minerva Medica 75(11): 561-563
Shorin, V.A.; Kunrat, L.A. 1974: Rifampicin pharmacokinetics in rabbits Antibiotiki 19(11): 978-981
Janowiec, M.; Zwolska-Kwiek, Z.; Wiśniewska, A.; Wróblewska, H. 1977: Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli Pneumonologia Polska 45(6): 425-430
Jaruratanasirikul, S. 1998: The pharmacokinetics of oral rifampicin in AIDS patients Journal of the Medical Association of Thailand 81(1): 25-28
Rao, S.; Singh, S.K.; Narang, R.K.; Rajagopalan, P.T. 1994: Effect of rifampicin on theophylline pharmacokinetics in human beings Journal of the Association of Physicians of India 42(11): 881-882
Ramachandran, G.; Hemanth Kumar, A.K.; Srinivasan, R.; Geetharani, A.; Sugirda, P.; Nandhakumar, B.; Nandini, R.; Tharani, C.B. 2012: Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin Indian Journal of Medical Research 136(6): 979-984
Makarenkova, R.V.; Kopeiko, I.P. 1977: Pharmacokinetics of rifampicin in single and repeated administration to patients with inflammatory processes in the lungs of nontuberculotic etiology Antibiotiki 22(3): 259-260
Cohen, V.I.; Rist, N.; Duponchel, C. 1977: Antitubercular activity of various thioacylurea derivatives Annales Pharmaceutiques Francaises 35(11-12): 509-513
Vazzana, I.; Sparatore, F.; Fadda, G.; Manca, C. 1993: N-[4-(R',R"-phenylazo)aryl]aminolupinanes with antitubercular activity Farmaco 48(6): 737-747
Vichkanova, S.A.; Tolkachev, O.N.; Makarova, L.V.; Tsizin, I.S. 1974: Structure and antitubercular activity of some diphenyl esters Farmakologiia i Toksikologiia 37(6): 711-715
Storozhuk, P.G.; Kolesnikov, V.V.; Korochanskaia, S.P.; Malan'ina, N.S.; Popova, I.A. 1985: Effect of antitubercular preparations on pancreatic proteinases and the proteolytic activity of the intestines Problemy Tuberkuleza 10: 49-52
Shapiro, A.A.; Meksin, V.A.; Abilev, S.K.; Akin'shina, L.P.; Fonshteĭn, L.M. 1978: Mutagenic activity of antitubercular preparations: isonicotinic acid hydrazide and its derivatives Tsitologiia i Genetika 12(4): 343-348
Rotmistrov, M.M.; Drabkina, R.I.; Kulik, G.V.; Ginzburg, T.S.; Skrinik, E.M. 1975: Study of the antitubercular activity of synthetic organic compounds belonging to the group based on Shiff, oxine and anilides Mikrobiolohichnyi Zhurnal 37(3): 385-386
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149